Enhancing Care in Type 1 Diabetes with Artificial Intelligence Driven Clinical Decision Support Systems

2.

Ogle

GD

,

Wang

F

,

Gregory

GA

,

Maniam

J

.

Type 1 diabetes estimates in children and adults

:

International Diabetes Federation

;

2022

.

3.

Hill-Briggs

F

,

Adler

NE

,

Berkowitz

SA

,

Chin

MH

,

Gary-Webb

TL

,

Navas-Acien

A

, et al.

Social determinants of health and diabetes: a scientific review

.

Diabetes Care

.

2020

;

44

(

1

):

258

–

79

.

4.

Ogunwole

SM

,

Golden

SH

.

Social determinants of health and structural inequities: root causes of diabetes disparities

.

Diabetes Care

.

2021

;

44

(

1

):

11

–

3

.

5.

Association of American Medical Colleges

.

The complexities of physician supply and demand: projections from 2021 to 2036

.

2024

.

6.

Patel

R

.

What is a diabetes decision

.

Now patient

.

2023

. https://nowpatient.com/blog/what-is-a-diabetes-decision (accessed January 8, 2025).

7.

Jendle

J

,

Adolfsson

P

,

Choudhary

P

,

Dovc

K

,

Fleming

A

,

Klonoff

DC

, et al.

A narrative commentary about interoperability in medical devices and data used in diabetes therapy from an academic EU/UK/US perspective

.

Diabetologia

.

2024

;

67

(

2

):

236

–

45

.

8.

Fleming

GA

,

Petrie

JR

,

Bergenstal

RM

,

Holl

RW

,

Peters

AL

,

Heinemann

L

.

Diabetes digital app technology: benefits, challenges, and recommendations. A consensus report by the European Association for the Study of Diabetes (EASD) and the American Diabetes Association (ADA) Diabetes Technology Working Group

.

Diabetologia

.

2020

;

63

(

2

):

229

–

41

.

9.

Edelman

S

,

Cheatham

WW

,

Norton

A

,

Close

KL

.

Patient perspectives on the benefits and challenges of diabetes and digital technology

.

Clin Diabetes

.

2024

;

42

(

2

):

243

–

56

.

10.

Tanenbaum

ML

,

Commissariat

PV

.

Barriers and facilitators to diabetes device adoption for people with type 1 diabetes

.

Curr Diab Rep

.

2022

;

22

(

7

):

291

–

9

.

11.

Papadakis

JL

,

Anderson

LM

,

Garza

K

,

Feldman

MA

,

Shapiro

JB

,

Evans

M

, et al.

Psychosocial aspects of diabetes technology use the child and family perspective

.

Endocrinol Metab Clin North Am

.

2020

;

49

(

1

):

127

–

41

.

12.

American Diabetes Association Professional Practice Committee

,

ElSayed

NA

,

Aleppo

G

.

9. Pharmacologic approaches to glycemic treatment: standards of care in diabetes-2024

.

Diabetes Care

.

2024

;

47

(

Suppl 1

):

S158

–

78

.

13.

Holt

RIG

,

DeVries

JH

,

Hess-Fischl

A

,

Hirsch

IB

,

Kirkman

MS

,

Klupa

T

, et al.

The management of type 1 diabetes in adults. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

.

Diabetologia

.

2021

;

64

(

12

):

2609

–

52

.

14.

American Diabetes Association Professional Practice Committee

,

ElSayed

NA

,

Aleppo

G

.

14. Children and adolescents: standards of care in diabetes-2024

.

Diabetes Care

.

2024

;

47

(

Suppl 1

):

S258

–

81

.

15.

Corathers

SD

,

DeSalvo

DJ

.

Therapeutic inertia in pediatric diabetes: challenges to and strategies for overcoming acceptance of the status quo

.

Diabetes Spectr

.

2020

;

33

(

1

):

22

–

30

.

16.

Khalifa

M

,

Albadawy

M

.

Artificial intelligence for diabetes: enhancing prevention, diagnosis, and effective management

.

Comput Methods Programs Biomed Updat

.

2024

;

5

:

100141

.

17.

Harrison

RM

,

Lapteva

E

,

Bibin

A

.

Behavioral nudging with generative AI for content development in SMS health care interventions: case study

.

JMIR

.

2024

;

3

:

e52974

.

18.

Huang

S

,

Liang

Y

,

Li

J

,

Li

X

.

Applications of clinical decision support systems in diabetes care: scoping review

.

J Med Internet Res

.

2023

;

25

:

e51024

.

19.

Clinical Decision Support Assistant Secretary for Technology Policy/Office of the National Coordinator for Health IT

. https://www.healthit.gov/policy-researchers-implementers/clinical-decision-support-cds (accessed October 8, 2024).

20.

Ackermann

K

,

Baker

J

,

Green

M

,

Fullick

M

,

Varinli

H

,

Westbrook

J

, et al.

Computerized clinical decision support systems for the early detection of sepsis among adult inpatients: scoping review

.

J Med Internet Res

.

2022

;

24

(

2

):

e31083

.

21.

Sutton

RT

,

Pincock

D

,

Baumgart

DC

,

Sadowski

DC

,

Fedorak

RN

,

Kroeker

KI

.

An overview of clinical decision support systems: benefits, risks, and strategies for success

.

Npj Digit Med

.

2020

;

3

(

1

):

17

.

22.

Kovatchev

B

,

Castillo

A

,

Pryor

E

,

Kollar

LL

,

Barnett

CL

,

DeBoer

MD

, et al.

Neural-net artificial Pancreas: a randomized crossover trial of a first-in-class automated insulin delivery algorithm

.

Diabetes Technol Ther

.

2024

;

26

(

6

):

375

–

82

.

23.

Hassan

S

,

Gujral

UP

,

Quarells

RC

,

Rhodes

EC

,

Shah

MK

,

Obi

J

, et al.

Disparities in diabetes prevalence and management by race and ethnicity in the USA: defining a path forward

.

Lancet Diabetes Endocrinol

.

2023

;

11

(

7

):

509

–

24

.

24.

Gurevich

E

,

Hassan

BE

,

Morr

CE

.

Equity within AI systems: what can health leaders expect

.

Healthc Manag Forum

.

2023

;

36

(

2

):

119

–

24

.

25.

Teixeira

PF

,

Battelino

T

,

Carlsson

A

,

Gudbjörnsdottir

S

,

Hannelius

U

,

von Herrath

M

, et al.

Assisting the implementation of screening for type 1 diabetes by using artificial intelligence on publicly available data

.

Diabetologia

.

2024

;

67

(

6

):

985

–

94

.

26.

Daniel

R

,

Jones

H

,

Gregory

JW

,

Shetty

A

,

Francis

N

,

Paranjothy

S

, et al.

Predicting type 1 diabetes in children using electronic health records in primary care in the UK: development and validation of a machine-learning algorithm

.

Lancet Digit Heal

.

2024

;

6

(

6

):

e386

–

95

.

27.

Herold

KC

,

Bundy

BN

,

Long

SA

,

Bluestone

JA

,

DiMeglio

LA

,

Dufort

MJ

, et al.

An anti-CD3 antibody, teplizumab, in relatives at risk for type 1 diabetes

.

N Engl J Med

.

2019

;

381

(

7

):

603

–

13

.

28.

Krischer

JP

,

Liu

X

,

Lernmark

Å

,

Hagopian

WA

,

Rewers

MJ

,

She

JX

, et al.

Predictors of the initiation of islet autoimmunity and progression to multiple autoantibodies and clinical diabetes: the TEDDY study

.

Diabetes Care

.

2022

;

45

(

10

):

2271

–

81

.

29.

Nakayasu

ES

,

Bramer

LM

,

Ansong

C

,

Schepmoes

AA

,

Fillmore

TL

,

Gritsenko

MA

, et al.

Plasma protein biomarkers predict the development of persistent autoantibodies and type 1 diabetes 6 months prior to the onset of autoimmunity

.

Cell Rep Med

.

2023

;

4

(

7

):

101093

.

30.

Prahalad

P

,

Scheinker

D

,

Desai

M

,

Ding

VY

,

Bishop

FK

,

Lee

MY

, et al.

Equitable implementation of a precision digital health program for glucose management in individuals with newly diagnosed type 1 diabetes

.

Nat Med

.

2024

;

30

(

7

):

2067

–

75

.

31.

Nimri

R

.

Decision support systems for insulin treatment adjustment in people with type 1 diabetes

.

Pediatr Endocrinol Rev

.

2020

;

17

(

Suppl 1

):

170

–

82

.

32.

Vega-López

S

,

Ausman

LM

,

Griffith

JL

,

Lichtenstein

AH

.

Interindividual variability and intra-individual reproducibility of glycemic index values for commercial white bread

.

Diabetes Care

.

2007

;

30

(

6

):

1412

–

7

.

33.

Amugongo

LM

,

Kriebitz

A

,

Boch

A

,

Lütge

C

.

Mobile computer vision-based applications for food recognition and volume and calorific estimation: a systematic review

.

Healthcare

.

2022

;

11

(

1

):

59

.

34.

Baumgartner

M

,

Kuhn

C

,

Nakas

CT

,

Herzig

D

,

Bally

L

.

Carbohydrate estimation accuracy of two commercially available smartphone applications vs estimation by individuals with type 1 diabetes: a comparative study

.

J Diabetes Sci Technol

.

2024

:

19322968241264744

.

35.

Rhyner

D

,

Loher

H

,

Dehais

J

,

Anthimopoulos

M

,

Shevchik

S

,

Botwey

RH

, et al.

Carbohydrate estimation by a mobile phone-based system versus self-estimations of individuals with type 1 diabetes mellitus: a comparative study

.

J Med Internet Res

.

2016

;

18

(

5

):

e101

.

36.

Lee

Y-B

,

Kim

G

,

Jun

JE

,

Park

H

,

Lee

WJ

,

Hwang

YC

, et al.

An integrated digital health care platform for diabetes management with AI-based dietary management: 48-week results from a randomized controlled trial

.

Diabetes Care

.

2023

;

46

(

5

):

959

–

66

.

37.

Perkins

BA

,

Turner

LV

,

Riddell

MC

.

Applying technologies to simplify strategies for exercise in type 1 diabetes

.

Diabetologia

.

2024

;

67

(

10

):

2045

–

58

.

38.

Reddy

R

,

Resalat

N

,

Wilson

LM

,

Castle

JR

,

El Youssef

J

,

Jacobs

PG

.

Prediction of hypoglycemia during aerobic exercise in adults with type 1 diabetes

.

J Diabetes Sci Technol

.

2019

;

13

(

5

):

919

–

27

.

39.

Kordonouri

O

,

Riddell

MC

.

Use of apps for physical activity in type 1 diabetes: current status and requirements for future development

.

Ther Adv Endocrinol Metab

.

2019

;

10

:

2042018819839298

.

40.

Jacobs

PG

,

Resalat

N

,

Hilts

W

,

Young

GM

,

Leitschuh

J

,

Pinsonault

J

, et al.

Integrating metabolic expenditure information from wearable fitness sensors into an AI-augmented automated insulin delivery system: a randomised clinical trial

.

Lancet Digit Heal

.

2023

;

5

(

9

):

e607

–

17

.

41.

Cooke

D

,

Bond

R

,

Lawton

J

,

Rankin

D

,

Heller

S

,

Clark

M

, et al.

Structured type 1 diabetes education delivered within routine care: impact on glycemic control and diabetes-specific quality of life

.

Diabetes Care

.

2013

;

36

(

2

):

270

–

2

.

42.

Alloatti

F

,

Bosca

A

,

Di Caro

L

,

Pieraccini

F

.

Diabetes and conversational agents: the AIDA project case study

.

Discov Artif Intell

.

2021

;

1

(

1

):

4

.

43.

Nassar

CM

,

Dunlea

R

,

Montero

A

,

Tweedt

A

,

Magee

MF

.

Feasibility and preliminary behavioral and clinical efficacy of a diabetes education chatbot pilot among adults with type 2 diabetes

.

J Diabetes Sci Technol

.

2025

;

19

(

1

):

54

–

62

.

44.

Nakhleh

A

,

Spitzer

S

,

Shehadeh

N

.

ChatGPT’s response to the diabetes knowledge questionnaire: implications for diabetes education

.

Diabetes Technol Ther

.

2023

;

25

(

8

):

571

–

3

.

45.

Hamed

E

,

Eid

A

,

Alberry

M

.

Exploring ChatGPT’s potential in facilitating adaptation of clinical guidelines: a case study of diabetic ketoacidosis guidelines

.

Cureus

.

2023

;

15

(

5

):

e38784

.

46.

Sng

GGR

,

Tung

JYM

,

Lim

DYZ

,

Bee

YM

.

Potential and pitfalls of ChatGPT and natural-language artificial intelligence models for diabetes education

.

Diabetes Care

.

2023

;

46

(

5

):

e103

–

5

.

47.

Sagstad

MH

,

Morken

N-H

,

Lund

A

,

Dingsør

LJ

,

Nilsen

ABV

,

Sorbye

LM

.

Quantitative user data from a chatbot developed for women with gestational diabetes mellitus: observational study

.

JMIR Form Res

.

2022

;

6

(

4

):

e28091

.

48.

Sharma

S

,

Pajai

S

,

Prasad

R

,

Wanjari

MB

,

Munjewar

PK

,

Sharma

R

, et al.

A critical review of ChatGPT as a potential substitute for diabetes educators

.

Cureus

.

2023

;

15

(

5

):

e38380

.

49.

Nimri

R

,

Dassau

E

,

Segall

T

,

Muller

I

,

Bratina

N

,

Kordonouri

O

, et al.

Adjusting insulin doses in patients with type 1 diabetes who use insulin pump and continuous glucose monitoring: variations among countries and physicians

.

Diabetes Obes Metab

.

2018

;

20

(

10

):

2458

–

66

.

50.

Nimri

R

,

Oron

T

,

Muller

I

,

Kraljevic

I

,

Alonso

MM

,

Keskinen

P

, et al.

Adjustment of insulin pump settings in type 1 diabetes management: advisor Pro device compared to physicians’ recommendations

.

J Diabetes Sci Technol

.

2022

;

16

(

2

):

364

–

72

.

51.

Nimri

R

,

Tirosh

A

,

Muller

I

,

Shtrit

Y

,

Kraljevic

I

,

Alonso

MM

, et al.

Comparison of insulin dose adjustments made by artificial intelligence-based decision support systems and by physicians in people with type 1 diabetes using multiple daily injections therapy

.

Diabetes Technol Ther

.

2022

;

24

(

8

):

564

–

72

.

52.

Nimri

R

,

Battelino

T

,

Laffel

LM

,

Slover

RH

,

Schatz

D

,

Weinzimer

SA

, et al.

Insulin dose optimization using an automated artificial intelligence-based decision support system in youths with type 1 diabetes

.

Nat Med

.

2020

;

26

(

9

):

1380

–

4

.

53.

Bergenstal

RM

,

Johnson

M

,

Passi

R

,

Bhargava

A

,

Young

N

,

Kruger

DF

, et al.

Automated insulin dosing guidance to optimise insulin management in patients with type 2 diabetes: a multicentre, randomised controlled trial

.

Lancet

.

2019

;

393

(

10176

):

1138

–

48

.

54.

Harper

R

,

Bashan

E

,

Williams

KJ

,

Sritharan

S

,

Willis

M

,

Marriott

DJ

, et al.

Challenging the 50-50 rule for the basal-bolus insulin ratio in patients with type 2 diabetes who maintain stable glycaemic control

.

Diabetes Obes Metab

.

2023

;

25

(

2

):

581

–

5

.

55.

Hermanns

N

,

Ehrmann

D

,

Finke-Groene

K

,

Krichbaum

M

,

Roos

T

,

Haak

T

, et al.

Use of smartphone application versus written titration charts for basal insulin titration in adults with type 2 diabetes and suboptimal glycaemic control (My Dose Coach): multicentre, open-label, parallel, randomised controlled trial

.

Lancet Reg Health Eur

.

2023

;

33

:

100702

.

56.

Nevoret

C

,

Gervaise

N

,

Delemer

B

,

Bekka

S

,

Detournay

B

,

Benkhelil

A

, et al.

The effectiveness of an app (insulia) in recommending basal insulin doses for French patients with type 2 diabetes mellitus: longitudinal observational study

.

JMIR Diabetes

.

2023

;

8

:

e44277

.

57.

Bisio

A

,

Anderson

S

,

Norlander

L

,

O'Malley

G

,

Robic

J

,

Ogyaadu

S

, et al.

Impact of a novel diabetes support system on a cohort of individuals with type 1 diabetes treated with multiple daily injections: a multicenter randomized study

.

Diabetes Care

.

2022

;

45

(

1

):

186

–

93

.

58.

Castle

JR

,

Wilson

LM

,

Tyler

NS

,

Espinoza

AZ

,

Mosquera-Lopez

CM

,

Kushner

T

, et al.

Assessment of a decision support system for adults with type 1 diabetes on multiple daily insulin injections

.

Diabetes Technol The

.

2022

;

24

(

12

):

892

–

7

.

59.

Huang

Y

,

Cheung

CY

,

Li

D

,

Tham

YC

,

Sheng

B

,

Cheng

CY

, et al.

AI-integrated ocular imaging for predicting cardiovascular disease: advancements and future outlook

.

Eye

.

2024

;

38

(

3

):

464

–

72

.

60.

Rajesh

AE

,

Davidson

OQ

,

Lee

CS

,

Lee

AY

.

Artificial intelligence and diabetic retinopathy: AI framework, prospective studies, head-to-head validation, and cost-effectiveness

.

Diabetes Care

.

2023

;

46

(

10

):

1728

–

39

.

61.

Wolf

RM

,

Liu

TYA

,

Thomas

C

,

Prichett

L

,

Zimmer-Galler

I

,

Smith

K

, et al.

The SEE study: safety, efficacy, and equity of implementing autonomous artificial intelligence for diagnosing diabetic retinopathy in youth

.

Diabetes Care

.

2021

;

44

(

3

):

781

–

7

.

62.

Wolf

RM

,

Channa

R

,

Liu

TYA

,

Zehra

A

,

Bromberger

L

,

Patel

D

, et al.

Autonomous artificial intelligence increases screening and follow-up for diabetic retinopathy in youth: the ACCESS randomized control trial

.

Nat Commun

.

2024

;

15

(

1

):

421

.

63.

American Diabetes Association Professional Practice Committee

,

ElSayed

NA

,

Aleppo

G

.

12. Retinopathy, neuropathy, and foot care: standards of care in diabetes-2024

.

Diabetes Care

.

2024

;

47

(

Suppl 1

):

S231

–

43

.

64.

Styles

CJ

.

Introducing automated diabetic retinopathy systems: it’s not just about sensitivity and specificity

.

Eye

.

2019

;

33

(

9

):

1357

–

8

.

65.

Zhong

Z

,

Yang

W

,

Zhu

C

,

Wang

Z

.

Role and progress of artificial intelligence in radiodiagnosing vascular calcification: a narrative review

.

Ann Transl Med

.

2023

;

11

(

2

):

131

–

0

.

66.

Zhao

D

,

Wang

W

,

Tang

T

,

Zhang

Y-Y

,

Yu

C

.

Current progress in artificial intelligence-assisted medical image analysis for chronic kidney disease: a literature review

.

Comput Struct Biotechnol J

.

2023

;

21

:

3315

–

26

.

67.

Anisuzzaman

DM

,

Wang

C

,

Rostami

B

,

Gopalakrishnan

S

,

Niezgoda

J

,

Yu

Z

.

Image-based artificial intelligence in wound assessment: a systematic review

.

Adv Wound Care

.

2022

;

11

(

12

):

687

–

709

.

68.

Yap

MH

,

Chatwin

KE

,

Ng

C-C

,

Abbott

CA

,

Bowling

FL

,

Rajbhandari

S

, et al.

A new mobile application for standardizing diabetic foot images

.

J Diabetes Sci Technol

.

2018

;

12

(

1

):

169

–

73

.

69.

Schaarup

JFR

,

Aggarwal

R

,

Dalsgaard

E-M

,

Norman

K

,

Dollerup

OL

,

Ashrafian

H

, et al.

Perception of artificial intelligence-based solutions in healthcare among people with and without diabetes: a cross-sectional survey from the health in Central Denmark cohort

.

Diabetes Epidemiol Management

.

2023

;

9

:

100114

.

70.

Laï

M-C

,

Brian

M

,

Mamzer

M-F

.

Perceptions of artificial intelligence in healthcare: findings from a qualitative survey study among actors in France

.

J Transl Med

.

2020

;

18

(

1

):

14

.

71.

Tucci

V

,

Saary

J

,

Doyle

TE

.

Factors influencing trust in medical artificial intelligence for healthcare professionals: a narrative review

.

J Med Artif Intell

.

2022

;

5

(

4

):

4

.